Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
229.00    1.00 (0.44%)
Bid:
228.50
Ask:
229.00
Spread: 0.50 (0.219%)
Market Cap: £632.99m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Interim Management Statement

19 Nov 2009 07:00

RNS Number : 7357C
Morgan Crucible Co PLC
19 November 2009
 



Press Release

Interim Management Statement

The Morgan Crucible Company plc

 

The Morgan Crucible Company plc - Interim Management Statement

The Morgan Crucible Company plc ('Morgan Crucible'), the advanced materials company, is issuing today its 'Interim Management Statement' regarding current trading, financial performance and outlook for the full year 2009. This statement constitutes Morgan Crucible's Interim Management Statement for the period from 5 July to 18 November 2009 as required by the UK Listing Authority's Disclosure and Transparency Rules.

Group performance for the second half of 2009 is anticipated to be in line with expectations 

End market demand in general has now stabilised having softened further during the summer as we anticipated

The benefits of the significant cost reductions we have made this year are expected to offset the impact of these lower revenue levels in the second half of the year

Commenting on the year to date performance and outlook, Mark Robertshaw, Chief Executive Officer, said:

"The Group's performance in the second half of the year has continued to demonstrate the significantly improved quality and resilience of Morgan Crucible's portfolio in what remains a challenging market environment. Our strategy of reducing the Group's exposure to economically cyclical markets has significantly mitigated the worst impacts of the global recession on our business and our margins.

Looking forward, I am cautiously optimistic that end market demand now appears to have stabilised in most areas although we think it is premature to suggest that a meaningful recovery is yet underway. Overall conditions in emerging markets, notably China and India, continue to look healthier than those in the Western world economies where demand generally remains subdued.

Throughout the year we have taken decisive actions to align our cost base to revenues and we believe these actions position us as a leaner and fitter business for when markets ultimately recover."

Carbon

Traditional Carbon business revenues continued to be impacted during the summer months by the economic downturn in our electrical and seal and bearing businesses and in some of our other niche markets, such as semi-conductor. Recent sales levels and order activity in most of our markets have now stabilised and in some there has been moderate increased activity in recent weeks, though it remains unclear as to whether this represents genuine end market recovery or a supply chain correction. We continue to expand our activities in the renewable energy sectors, with new initiatives in solar, wind and energy storage holding promise for future growth.

US Body armour sales remain considerably below 2008 levels, however we have secured further orders outside of the US for delivery over the coming months. 

Our aggressive cost reduction actions that began towards the end of 2008 have reduced the impact of the large decline in our end markets. Permanent headcount in the Carbon business has been reduced by approximately 15% and short time working is in place at a number of sites. Capital expenditure remains very tightly controlled and there is an ongoing focus on working capital reduction to ensure that cash generation is maximised.

NP Aerospace is trading in line with expectations, as the business has continued to deliver against major vehicle programmes for the UK Ministry of Defence. The current NP Aerospace order book provides good visibility over the coming months and there are a number of ongoing initiatives in the UK and overseas that present further opportunities to leverage the global reach and materials technology of the business.

Technical Ceramics 

During the year, Technical Ceramics has maintained its focus on positive mix shift moving towards higher margin, higher value added end markets such as medical and aerospace. In parallel, our continuous operational improvement programme, our cost reduction initiatives, and our emphasis on positive price pass through are all contributing to supporting operating margins in very difficult market conditions. 

Although the overall market demand has declined in 2009 there are some areas that have shown recent signs of improvement. The US market appears to have stabilised although we continue to watch carefully for any signs of a further downturn. Some weakness in the aerospace and industrial gas turbine sector is being offset by improvements in demand from semi-conductor and telecoms markets. We are also beginning to ramp-up the next generation of Hard Disc drive products. Our European business has had a difficult year being consistently challenged by weak market conditions in general industrial markets and construction. This principally affects our thermal processing business in GermanySince the half year we have also seen a reduction in Industrial gas turbine demand. In both Europe and North America a highlight of 2009 has been the continuing strength of our medical customers. Developing our exposure to this sector remains an important focus for the Division.

Work on consolidating our footprint has continued in the second half of the year. We announced and have initiated the move of business from our Auburn site into the Hayward location in California and expect to see the benefits of this during 2010

Insulating Ceramics

As anticipated, overall end-market demand for Thermal Ceramics continued to weaken during the summer months but in recent weeks appears to be stabilising. Order books in emerging markets, particularly China and India, have been showing a modest improvement and appear to be flattening out in North America and Europe.

The chemical and petroleum sector remains quite robust with good demand in the Middle East and Latin America. Iron and steel demand is recovering somewhat from a very low base and so too sales to the automotive industry. The majority of other end markets, whilst generally not worsening any further, are as yet showing little sign of recovery.

Cost reduction initiatives have continued into the second half including the successful closure of two small fibre production sites in North America and Europe, which will help mitigate the lower revenues in the second half of the year.

Revenues in Molten Metal Systems (MMS) have improved in the second half of the year driven by modest recovery in Asia and Europe. Margins are anticipated to improve over the first half, benefiting from the reduction in operating costs implemented in H1, particularly in GermanyThe expanded Indian operation, which continues to perform well, together with the new plant in China means that MMS is well positioned to benefit from the global recovery with a much reduced fixed cost base.

Financial position

There was no material change in the financial position of the Group during the period.

Our expectation for the full year, at present foreign exchange rates, is that our net debt/EBITDA ratio will be broadly in line with the 2008 year end and H1 2009 positions.

Outlook

The Group continues to face a challenging economic environment, although encouragingly, demand now generally appears to have stabilised. We believe that our strategy of focussing on less economically cyclical markets has successfully mitigated the worst impacts of the downturn. Furthermore, the decisive actions on aligning our cost base to revenues leaves us well placed to benefit as markets recover.

For further enquiries:

Mark Robertshaw

Morgan Crucible

01753 837300

Kevin Dangerfield

Mike Smith / Clare Hunt

Finsbury

020 7251 3801


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBRUBGGCI
Date   Source Headline
19th Sep 201610:52 amRNSDirector/PDMR Shareholding
13th Sep 201611:43 amRNSDirector/PDMR Shareholding
23rd Aug 20163:59 pmRNSHolding(s) in Company
28th Jul 201611:40 amRNSHolding(s) in Company
27th Jul 20167:00 amRNSHalf-Year Results
29th Jun 20161:19 pmRNSHolding(s) in Company
29th Jun 20161:16 pmRNSHolding(s) in Company - Amendment
22nd Jun 201611:59 amRNSHolding(s) in Company
20th Jun 201611:22 amRNS2015 Environmental, Health and Safety Report
15th Jun 201610:18 amRNSBlock listing Interim Review
31st May 20162:55 pmRNSDirector/PDMR Shareholding
24th May 201612:31 pmRNSDirector/PDMR Shareholding
6th May 20162:23 pmRNSResult of AGM
6th May 20167:00 amRNSTrading update
18th Apr 20162:39 pmRNSDirector/PDMR Shareholding
8th Apr 20167:00 amRNSAppointment of Non-Executive Director
7th Apr 20164:30 pmRNSDirector/PDMR Shareholding
6th Apr 20161:18 pmRNSAnnual Financial Report
5th Apr 20167:00 amRNSDirectorate Change
30th Mar 20167:00 amRNSAppointment of Chief Financial Officer
24th Mar 20167:00 amRNSBoard Change
24th Feb 20161:08 pmRNSDirector/PDMR Shareholding
23rd Feb 20167:00 amRNSFinal Results
4th Feb 201610:56 amRNSDirectorate Change
1st Feb 20161:56 pmRNSDirector Declaration
22nd Jan 20167:00 amRNSAppointment of a Non-Executive Director
14th Jan 201612:33 pmRNSHolding(s) in Company
30th Dec 201510:10 amRNSDirector/PDMR Shareholding
18th Dec 20152:22 pmRNSDirector/PDMR Shareholding
16th Dec 20151:26 pmRNSAdoption of FRS 101 - Reduced Disclosure Framework
15th Dec 20153:56 pmRNSHolding(s) in Company
15th Dec 20153:16 pmRNSBlocklisting Interim Review
2nd Dec 20159:10 amRNSHolding(s) in Company
26th Nov 201512:22 pmRNSDirector/PDMR Shareholding
24th Nov 20153:25 pmRNSHolding(s) in Company
13th Nov 201512:18 pmRNSDirector/PDMR Shareholding
12th Nov 20157:00 amRNSTrading Update
9th Oct 201511:14 amRNSHolding(s) in Company
2nd Oct 20157:00 amRNSBoard Change
29th Sep 20152:47 pmRNSDirector/PDMR Shareholding
25th Sep 201510:43 amRNSDirector Declaration
17th Sep 201511:50 amRNSHolding(s) in Company
11th Sep 201511:23 amRNSHolding(s) in Company
10th Sep 20153:21 pmRNSHolding(s) in Company
2nd Sep 20159:11 amRNSDirector/PDMR Shareholding
20th Aug 201512:07 pmRNSDirector/PDMR Shareholding
4th Aug 201510:13 amRNSDirector/PDMR Shareholding
22nd Jul 20157:00 amRNSHalf Yearly Results
2nd Jul 20155:22 pmRNSHolding(s) in Company
15th Jun 20153:53 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.